UNSPSC 51292904: Desipramine

This classification denotes a tricyclic antidepressant with the molecular formula C18H22N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TG537D343B, chemically known as 10,11-dihydro-5-(3-methylaminopropyl)-5h-dibenz(b,f)azepine but generally known as desipramine, which bears US NIH Compound Identifier 2995. European Medicines Agency schedules Desipramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06995MIG.

UNSPSC 51292904 Desipramine is a Commodity code that nominally designates a specific tricyclic antidepressant medication; however, the single recent state and local opportunity tagged to this code shows a mismatch between the code assignment and the actual procurement. Seminole County, Florida posted an IFB in June 2026 for naloxone and drug deactivation systems—emergency overdose-response and medication-disposal products unrelated to desipramine. The procurement specifies 1,900 units of naloxone and 800 safe drug deactivation systems on an annual basis, with quarterly deliveries required to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their bids, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract carries a two-year initial term with an option for one-year renewal and includes a three-month probationary period allowing termination with or without cause.

The code shows minimal recent activity. The single opportunity originates in Florida and reflects what appears to be an administrative or coding error rather than genuine demand for desipramine itself. Because the Seminole County procurement targets naloxone and drug deactivation systems instead, this Commodity code does not reliably signal state and local demand for desipramine pharmaceuticals. Firms evaluating this code should confirm whether their product line actually aligns with desipramine supply or whether the recent opportunity represents an outlier caused by misclassification in the issuing jurisdiction's procurement taxonomy.